Logo image of WRD

WERIDE INC-ADR (WRD) Stock Fundamental Analysis

NASDAQ:WRD - Nasdaq - US9509151083 - ADR

13.39  +0.57 (+4.45%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to WRD. WRD was compared to 83 industry peers in the Automobile Components industry. While WRD seems to be doing ok healthwise, there are quite some concerns on its profitability. WRD does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year WRD has reported negative net income.
WRD had a negative operating cash flow in the past year.
WRD Yearly Net Income VS EBIT VS OCF VS FCFWRD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 -500M -1B -1.5B

1.2 Ratios

WRD's Return On Assets of -37.77% is on the low side compared to the rest of the industry. WRD is outperformed by 93.98% of its industry peers.
Industry RankSector Rank
ROA -37.77%
ROE N/A
ROIC N/A
ROA(3y)-29.96%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
WRD Yearly ROA, ROE, ROICWRD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 0 20 -20 40 60 80 100

1.3 Margins

WRD's Gross Margin of 45.66% is amongst the best of the industry. WRD outperforms 97.59% of its industry peers.
WRD does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 45.66%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
WRD Yearly Profit, Operating, Gross MarginsWRD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 0 -200 -400 -600

More info and screens

4

2. Health

2.1 Basic Checks

WRD does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for WRD remains at a similar level compared to 1 year ago.
Compared to 1 year ago, WRD has an improved debt to assets ratio.
WRD Yearly Shares OutstandingWRD Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 50M 100M 150M 200M 250M
WRD Yearly Total Debt VS Total AssetsWRD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 1B 2B 3B 4B 5B

2.2 Solvency

Based on the Altman-Z score of 0.64, we must say that WRD is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.64, WRD is not doing good in the industry: 87.95% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 0.64
ROIC/WACCN/A
WACC7.53%
WRD Yearly LT Debt VS Equity VS FCFWRD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 -1B -2B -3B

2.3 Liquidity

WRD has a Current Ratio of 13.64. This indicates that WRD is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 13.64, WRD belongs to the top of the industry, outperforming 98.80% of the companies in the same industry.
WRD has a Quick Ratio of 12.89. This indicates that WRD is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 12.89, WRD belongs to the best of the industry, outperforming 98.80% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 13.64
Quick Ratio 12.89
WRD Yearly Current Assets VS Current LiabilitesWRD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 1B 2B 3B 4B 5B

More info and screens

0

3. Growth

3.1 Past

The earnings per share for WRD have decreased strongly by -54.38% in the last year.
Looking at the last year, WRD shows a very negative growth in Revenue. The Revenue has decreased by -23.83% in the last year.
EPS 1Y (TTM)-54.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-23.83%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
WRD Yearly Revenue VS EstimatesWRD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 100M 200M 300M 400M 500M
WRD Yearly EPS VS EstimatesWRD Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

WRD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
WRD Price Earnings VS Forward Price EarningsWRD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
WRD Per share dataWRD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1 -1.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

WRD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

WERIDE INC-ADR

NASDAQ:WRD (1/22/2025, 11:41:15 AM)

13.39

+0.57 (+4.45%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner Change0%
Ins OwnersN/A
Ins Owner Change0%
Market Cap3.68B
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short Ratio1.03
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 66.63
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.32
FCFYN/A
OCF(TTM)-0.29
OCFYN/A
SpS0.2
BVpS-1.84
TBVpS-1.87
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -37.77%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 45.66%
FCFM N/A
ROA(3y)-29.96%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 101.48%
Cap/Sales 13.49%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 13.64
Quick Ratio 12.89
Altman-Z 0.64
F-ScoreN/A
WACC7.53%
ROIC/WACCN/A
Cap/Depr(3y)93.03%
Cap/Depr(5y)N/A
Cap/Sales(3y)14.48%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-54.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-23.83%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-101.1%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y32.03%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y29.16%
OCF growth 3YN/A
OCF growth 5YN/A